MAP3K1 and colorectal carcinoma: MEKK1 was expressed at high levels in 71.6% (202/282) of CRC cancer tissues, 212 (75.2%) patients showed high expression of MEK1, and 158 (56.0%) patients showed high expression of p-ERK (Fig. 6B).